A clinical briefing for providers on Benzoyl Peroxide availability in 2026, including benzene recall timeline, prescribing guidance, and patient tools.
Over the past two years, Benzoyl Peroxide — one of dermatology's most relied-upon topical agents — has faced an unprecedented wave of scrutiny, recalls, and reformulations. While the ingredient itself is not in shortage, your patients may be struggling to fill prescriptions or find their preferred OTC products. This guide summarizes the current landscape for dermatologists, primary care providers, nurse practitioners, and physician assistants prescribing Benzoyl Peroxide in 2026.
For a complementary guide on practical steps to help patients locate medications, see our provider's guide to helping patients find Benzoyl Peroxide.
Independent testing lab Valisure published findings in the Journal of Investigative Dermatology indicating that certain Benzoyl Peroxide acne products could generate benzene — a known carcinogen — when subjected to elevated temperatures. The study found that approximately one-third of products tested at room temperature exceeded the FDA's conditional benzene limit of 2 parts per million (ppm).
The FDA conducted its own testing of 95 acne products containing Benzoyl Peroxide. Results showed that the majority of products tested within acceptable limits, but a small number had elevated benzene levels. The FDA issued public alerts and coordinated with manufacturers.
Manufacturers voluntarily recalled specific product lots with elevated benzene levels:
At the American Academy of Dermatology 2025 annual meeting, researchers including Dr. Christopher Bunick emphasized the need for practical approaches to Benzoyl Peroxide use while awaiting regulatory action. The consensus was that Benzoyl Peroxide remains a valuable treatment, and the focus should be on product formulation improvements rather than abandonment of the agent.
Research published in JAMA Dermatology demonstrated that incorporating antioxidants such as BHT into Benzoyl Peroxide formulations can significantly reduce benzene formation, even under elevated-temperature conditions. Multiple manufacturers are now reformulating their products accordingly.
The 2024 AAD guidelines continue to recommend Benzoyl Peroxide as a foundational acne treatment. Key recommendations include:
The guidelines do not advise against Benzoyl Peroxide use based on the benzene findings.
As of March 2026:
Benzoyl Peroxide remains one of the most affordable topical acne treatments:
For patients facing cost barriers, provider tools at Medfinder for Providers can help identify the most affordable options and check local pharmacy availability.
The Benzoyl Peroxide landscape is evolving in positive directions:
Benzoyl Peroxide remains a cornerstone of acne management, and the current availability challenges are primarily logistical rather than clinical. By staying informed about the recall landscape, prescribing flexibly, and directing patients to tools like Medfinder for Providers, you can help ensure your patients maintain access to this essential treatment.
For practical guidance on helping patients navigate the current landscape, see our companion article: How to Help Your Patients Find Benzoyl Peroxide in Stock.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
